| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Betta Pharmaceuticals Co. Ltd (SHE: 300558)
300558 Technical Analysis
4
| As on 9th Jun 2023 300558 STOCK Price closed @ 51.69 and we RECOMMEND Sell for LONG-TERM with Stoploss of 55.64 & Strong Sell for SHORT-TERM with Stoploss of 73.47 we also expect STOCK to react on Following IMPORTANT LEVELS. |
300558STOCK Price
| Open | 49.20 | Change | Price | % |
| High | 52.34 | 1 Day | 2.64 | 5.38 |
| Low | 48.81 | 1 Week | -4.68 | -8.30 |
| Close | 51.69 | 1 Month | -14.39 | -21.78 |
| Volume | 7085625 | 1 Year | -30.19 | -36.87 |
| 52 Week High 83.23 | 52 Week Low 39.85 | ||||
SHE China Most Active Stocks
| 000100 | 3.90 | 1.04% |
| 300315 | 6.32 | 19.92% |
| 002602 | 7.57 | 10.03% |
| 300459 | 6.89 | 4.71% |
| 000725 | 4.00 | 1.78% |
| 300002 | 14.07 | 9.92% |
| 300058 | 10.87 | 1.68% |
| 002354 | 7.41 | 4.66% |
| 300059 | 14.23 | -1.59% |
| 002292 | 11.19 | -4.44% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
| 300558 Daily Charts |
300558 Intraday Charts |
Whats New @ Bazaartrend |
300558 Free Analysis |
|
|
300558 Important Levels Intraday
| RESISTANCE | 58.49 |
| RESISTANCE | 56.31 |
| RESISTANCE | 54.96 |
| RESISTANCE | 53.61 |
| SUPPORT | 49.77 |
| SUPPORT | 48.42 |
| SUPPORT | 47.07 |
| SUPPORT | 44.89 |
300558 Forecast June 2024
| 4th UP Forecast | 91.77 |
| 3rd UP Forecast | 78.92 |
| 2nd UP Forecast | 70.97 |
| 1st UP Forecast | 63.03 |
| 1st DOWN Forecast | 40.35 |
| 2nd DOWN Forecast | 32.41 |
| 3rd DOWN Forecast | 24.46 |
| 4th DOWN Forecast | 11.61 |
300558 Weekly Forecast
| 4th UP Forecast | 58.76 |
| 3rd UP Forecast | 56.49 |
| 2nd UP Forecast | 55.09 |
| 1st UP Forecast | 53.69 |
| 1st DOWN Forecast | 49.69 |
| 2nd DOWN Forecast | 48.29 |
| 3rd DOWN Forecast | 46.89 |
| 4th DOWN Forecast | 44.62 |
300558 Forecast2024
| 4th UP Forecast | 136.21 |
| 3rd UP Forecast | 109.1 |
| 2nd UP Forecast | 92.35 |
| 1st UP Forecast | 75.59 |
| 1st DOWN Forecast | 27.79 |
| 2nd DOWN Forecast | 11.03 |
| 3rd DOWN Forecast | -5.72 |
| 4th DOWN Forecast | -32.83 |
Betta Pharmaceuticals Co. Ltd ( SHE China Symbol : 300558 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
300558 Business Profile
Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer. Betta Pharmaceuticals Co., Ltd. was founded in 2003 and is headquartered in Hangzhou, China. Address: No. 355, Xingzhong Road, Hangzhou, China
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service